Journal List > J Korean Ophthalmol Soc > v.51(5) > 1008803

Lee, Lee, Park, and Lee: Clinical Research on Surgical Treatment for Double-Head Pterygium

Abstract

Purpose

To evaluate two surgical methods-amniotic membrane transplantation (AMT) and split-conjunctival grafts (SCG)-for double-head pterygium, with regard to the postoperative outcome and recurrence rate.

Methods

In a total of 16 eyes (14 patients), 7 eyes (6 patients) receiving amniotic membrane transplantation and 9 eyes (8 patients) receiving split-conjunctival grafts were compared to evaluate recurrence and complications.

Results

Within the amniotic membrane transplantation group, two eyes (29%) had corneal recurrence, and 3 eyes (43%) had conjunctival recurrence. The mean follow-up period was 21.9±3.5 months, and all recurrences were on the nasal side. The average period preceding the corneal recurrences was 7.2±1.8 months. Within the split-conjunctival grafts group, the mean fol-low-up was 13.6±2.1 months, and neither the corneal nor conjunctival recurrences were observed. In addition, the eyes of this group were more aesthetically stable, with only one eye exhibiting pseudo-pterygium at the donor site.

Conclusions

In cases of double-head pterygium without contraindication of conjunctival autograft, the split-conjunctival grafts produced fewer recurrences and showed enhanced cosmetic results, as compared to the amniotic membrane transplantation, indicating that the split-conjunctival grafts is the superior choice over amniotic membrane transplantation.

References

1. Kenyon KR, Wagoner MD, Hettinger ME. Conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology. 1985; 92:1461–70.
crossref
2. Prabhasawat P, Barton K, Burkett G, Tseng SC. Comparison of abdominal autografts, amniotic membrane grafts, and primary closure for pterygium excision. Ophthalmology. 1997; 104:974–85.
3. Sanchez-Thorin JC, Rocha G, Yelin JB. Meta-analysis on the abdominal rates after bare sclera resection with and without mitomycin C use and conjunctival autograft placement in surgery for primary pterygium. Br J Ophthalmol. 1998; 82:661–5.
4. Ma DH, See LC, Liau SB, Tsai RJ. Aminotic membrane graft for abdominal pterygium: comparision with conjunctival autograft and topical mitomycin C treatment. Br J Ophthalmol. 2000; 84:973–8.
5. Hirst LW. Prospective study of primary pterygium surgery using pterygium extended removal followed by extended conjunctival transplantation. Ophthalmology. 2008; 115:1663–72.
crossref
6. Solomon A, Pires RT, Tseng SC, et al. Amniotic membrane abdominal after extensive removal of primary and recurrent pterygia. Ophthalmology. 2001; 108:449–60.
7. Avisar R, Snir M, Weinberger D. Outcome of double-head pterygium surgery. Cornea. 2003; 22:501–3.
8. Maheshwari S. Split-conjunctival grafts for double-head pterygium. Indian J Ophthalmol. 2005; 53:53–5.
9. Wu WK, Wong VW, Chi SC, Lam DS. Surgical management of dou-ble-head pterygium by using a novel technique: conjunctival rotational autograft combined with conjunctival autograft. Cornea. 2007; 26:1056–9.
10. Rubinfeld RS, Pfister RR, Stein RM, et al. Serious complications of topical mitomycin C after pterygium surgery. Ophthalmology. 1992; 99:1647–54.
11. Safianik B, Ben-Zion I, Garzozi HJ. Serious corneoscleral complications after pterygium excision with mitomycin C. Br J Ophthalmol. 2002; 86:357–8.
crossref
12. Ti SE, Tan DT. Tectonic corneal lamellar grafting for severe scleral melting after pterygium surgery. Ophthalmology. 2003; 110:1126–36.
crossref
13. Wan Norliza WM, Raihan IS, Azwa JA, Ibrahim M. Scleral melting 16 years after pterygium excision with topical Mitomycin C adjuvant therapy. Cont Lens Anterior Eye. 2006; 29:165–7.
crossref
14. Jang JH, Choi TH. The effect of amniotic membrane transplantation for pterygium excision. J Korean Ophthalmol Soc. 2005; 46:597–604.
15. Katircioglu YA, Altiparmak UE, Duman S. Comparison of three methods for the treatment of pterygium: amniotic membrane graft, conjunctival autograft and conjunctival autograft plus mitomycin C. Orbit. 2007; 26:5–13.
crossref
16. Kim YI, Paek KU, Park HS. Ocular surface reconstruction with abdominal membrane transplantation in pterygium. J Korean Ophthalmol Soc. 1999; 40:1178–83.
17. Kim MJ, Tchah HW. Treatment of pterygium with amniotic abdominal transplantation. J Korean Ophthalmol Soc. 1998; 39:59–64.
18. Tananuvat N, Martin T. The results of amniotic membrane transplantation for primary pterygium compared with conjunctival autograft. Cornea. 2004; 23:458–63.
crossref
19. Hirst LW. The treatment of pterygium. Surv Ophthalmol. 2003; 48:145–80.
crossref
20. John T. Pterygium excision and conjunctival mini-autograft: Preliminary report. Eye. 2001; 15:292–6.
crossref
21. Dupps WJ Jr, Jeng BH, Meisler DM. Narrow-strip conjunctival abdominal for treatment of pterygium. Ophthalmology. 2007; 114:227–31.
22. Coroneo MT, Di Girolam N, Wakefield D. The pathogenesis of pterygia. Curr Opin Ophthalmol. 1999; 10:282–8.
crossref
23. Yoon KC, Heo H, Jeong IY, Park YG. The use of fibrin glue for abdominal autotransplantation in pterygium. J Korean Ophthalmol Soc. 2006; 47:198–204.
24. Koranyi G, Seregard S, Kopp ED. Cut and paste: a no suture, small abdominal approach to pterygium surgery. Br J Ophthalmol. 2004; 88:911–4.
26. Kim HH, Mun HJ, Park YJ, et al. Conjunctivolimbal autograft using a fibrin adhesive in pterygium surgery. Korean J Ophthalmol. 2008; 22:147–54.
crossref
27. Dolezalova V. Is the occurrence of a temporal pterygium really so rare? Ophthalmologica. 1977; 174:88–91.
crossref

Figure 1.
Surgical procedure of split-conjunctival grafts for double-head pterygium. (A) The temporal and nasal side pterygium is along with adjacent fibrovascular tissue. (B, C) Conjunctival graft (6 mm) is dissected from the fornix leaving the underlying Tenon's capsule intact, flipped over the cornea. (D, E) From the donor conjunctiva, the distal 3 mm is excised and attached to the temporal bare sclera area using tissue adhesives. (F, G, H) The remaining graft is excised all the way down to the limbus, and attached to the nasal bare sclera area using tissue adhesives. (I) To protect and stabilize the conjunctiva autograft, temporary amniotic membrane transplantation is applied onto the whole eye with 10–0 nylon suture left in place for 5∼7 days.
jkos-51-642f1.tif
Figure 2.
Pre and postoperative photographs for amniotic membrane transplantation group. (A, B1) Preoperative photograghs of double-head pterygium. (A, B2) The transplanted amniotic membrane seems to blend in with stable ocular surface at 3 months postoperatively. (A3) Conjunctival recurrence at 5 months postoperatively. (B3, B4) Shows corneal recurrence at 9 months postoperatively, and the following stabilization after limbal-conjunctival autograft.
jkos-51-642f2.tif
Figure 3.
Pre and postoperative photogragh for split-conjunctival grafts group. (A, B1) Preoperative photograghs of double-head pterygium. (A, B2) Well-positioned graft and quiet conjunctival surface are observed in subjects at 1 month postoperatively. (A, B3) Normal appearance is seen and recurrence of pterygium is not recognized in subjects at 12 months postoperatively.
jkos-51-642f3.tif
Table 1.
Demographic data of patients in the two study groups
  AMT* Split-conjunctival graft
Number of eyes (patients) 7 (6) 9 (8)
Primary / Recurrent (eyes) 5 / 2 7 / 2
Age (years) (range) 60.1±7.9 (48∼72) 59.0±9.9 (44∼78)
Gender (Male:Female) 4: 3 3: 6
Follow-up (months) (range) 21.9±3.5 (18∼27) 13.6±2.1 (12∼18)

* AMT=amniotic membrane transplantation.

Table 2.
Summary of surgical results within amniotic membrane transplantation group
Case Age/Sex Primary/ Follow-up VA* change Corneal astigmatism change
    Recurrent (months)   (Diopter)
1 48/M Primary 24 0.7 → 1.0 0.5 → 0.25
2 66/M Primary 18 0.15 → 0.5 4 → 0.75
3 72/M Recurrent 27 0.06 → 0.2 13.25 → 4.25
4 61/F Primary 19 0.4 → 0.4 Error → 3
5 61/F Recurrent 18 0.06 → 0.4 Error → 6.25
6 60/F Primary 24 0.7 → 0.8 0.75 → 1.0
7 53/M Primary 23 0.9 → 0.9 6.25 → 0.5

* VA=visual acuity.

Table 3.
Summary of surgical results within split-conjunctival grafts group
Case Age/Sex Primary/ Follow-up VA* change Co orneal astigmatism change
    Recurrent (months)   (diopter)
1 44/F Primary 13 0.7 → 1.0 1 → 0.5
2 55/F Primary 18 0.3 → 0.5 11.5 → 0.5
3 60/M Primary 12 0.8 → 0.7 Error → 1.25
4 55/F Primary 15 0.3 → 0.7 Error → 3.25
5 61/F Primary 13 0.5 → 0.5 1 → 0.5
6 65/F Recurrent 15 0.6 → 0.9 0.75 → 0.75
7 54/F Recurrent 12 0.8 → 1.0 0.75 → 1
8 78/M Primary 12 0.06 → 0.4 Error → 1.75
9 78/M Primary 12 0.06 → 0.2 11.25 → 1

*VA=visual acuity.

Table 4.
Recurrence and complications of the two study groups
  AMT* Split-conjunctival graft
G2 (conjunctival recurrence) 3/7 (43%) 0/9 (0%)
G3 (corneal recurrence) 2/7 (29%) 0/9 (0%)
Location of recurrence Nasal: 5/5 (100%) ·
Mean recurrent period (months) (range) 7.2±1.8 (5∼9) ·
Complication    
   Vascularization at donor site 0 1
   Subgraft hemorrhage 2 2

* AMT=amniotic membrane transplantation

Excessive fibrovascular tissue proliferation at donor site (similar to pseudopterygium).

Table 5.
Previous reports on surgical treatment for double-head pterygium
Author(s) Pterygium Number Surgery technique Mean follow-up Recurrence
  type of eyes   (months) rate (%)
Solomon et al6 Primary 11 Extensive pterygium excision with AMT 12.8±4.3 1/11 (9%)
Avisar et al7 Primary 10 Bare sclera technique with 36.3±3.8 0/10 (0%)
  Recurrent 3 0.02% MMC* (5 minutes) 28.4±2.7 1/3 (33%)
Maheshwari et al8 Primary 7 Split-conjunctival graft 17.7±6.0 0/7 (0%)
Wu et al9 Primary 20 Conjunctival rotational autograft combined 22.6 7/20 (35%)
      with conjunctival autograft    

* MMC=mitomycin C

AMT=amniotic membrane transplantation

Recurrence rate is defined as fibrovascular tissue invading the cornea.

TOOLS
Similar articles